Real-World allergy treatment under the microscope
NCT ID NCT07412990
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks how adults with grass pollen allergy use Grassmuno® in everyday medical practice. Researchers will monitor treatment adherence and injection schedules over two years. The goal is to understand how well patients stick with the therapy and how it controls their symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRASS POLLEN ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Kasche
RECRUITINGHamburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.